OBJECTIVE: To study the clinical effects of Reduning Injection on ordinary @entity5825 ( @entity5825 ) in @entity1 . METHODS: 76 @entity1 with confirmed diagnosis of @entity5825 were randomly assigned to 3 groups by the center randomization method, i.e., the Western medicine group (WM, 24 cases, treated with @entity5371 Injection or antibiotics), the Reduning Injection group (RI, 26 cases, treated with Reduning Injection), and the combination group (26 cases, treated with the combination of Reduning injection with @entity5371 Injection or antibiotics). The therapeutic course lasted for 3 to 7 days. A 3-day follow-up study was performed by the end of the treatment. The blood routines, the liver function, the renal function, the fasting blood @entity413 , the pyretolysis effect initiating time, the time for the body temperature recovery, and the @entity1910 subside time were observed in the three groups. RESULTS: (1) Of 76 @entity1 , 13 dropped out, with the final effective case being 63. Of them, there were 19 cases in the WM group, 22 in the RI group, and 22 in the combination group. (2) Compared with the WM group, the pyretolysis effect initiating time and the time for the body temperature recovery were both significantly shortened in the RI group and the combination group (P<0.05, P<0.01). (3) There was no significant difference in the @entity1910 subside time among the three groups (P>0.05). But there was shortening tendency in the RI group and the combination group. (4) One @entity1 in the RI group dropped out from this study due to a mild @entity1910 , and no adverse drug reaction occurred in the other two groups. CONCLUSIONS: RI had some advantages in treatment of @entity5825 such as fasting pyretolysis effect initiating time, shorter time for the body temperature recovery, higher safety. Besides, it also could accelerate the subside of @entity1910 to some extent.

[Effect of reducing injection on @entity5825 in XXXX : a randomized controlled trial].

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'child'] @entity1910 :: ('MESH:D005076', 'Disease') :: ['skin rashes', 'rash'] @entity5825 :: ('MESH:D006232', 'Disease') :: ['HFMD', 'hand, foot and mouth disease'] @entity5371 :: ('MESH:D012254', 'Chemical') :: ['Ribavirin'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose']
@entity1 :: (9606,Species) :: ['children']
